Your browser doesn't support javascript.
loading
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma.
Manier, Salomon; Huynh, Daisy; Shen, Yu J; Zhou, Jia; Yusufzai, Timur; Salem, Karma Z; Ebright, Richard Y; Shi, Jiantao; Park, Jihye; Glavey, Siobhan V; Devine, William G; Liu, Chia-Jen; Leleu, Xavier; Quesnel, Bruno; Roche-Lestienne, Catherine; Snyder, John K; Brown, Lauren E; Gray, Nathanael; Bradner, James; Whitesell, Luke; Porco, John A; Ghobrial, Irene M.
Afiliação
  • Manier S; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA. irene_ghobrial@dfci.harvard.edu salomon_manier@dfci.harvard.edu.
  • Huynh D; Department of Hematology, Lille Hospital, 59000 Lille, France.
  • Shen YJ; INSERM UMR-S 1172, University of Lille 2, 59000 Lille, France.
  • Zhou J; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.
  • Yusufzai T; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.
  • Salem KZ; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.
  • Ebright RY; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.
  • Shi J; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.
  • Park J; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.
  • Glavey SV; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.
  • Devine WG; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.
  • Liu CJ; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.
  • Leleu X; Boston University Center for Molecular Discovery, Boston, MA 02215, USA.
  • Quesnel B; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.
  • Roche-Lestienne C; Department of Hematology, University Hospital of Poitiers, 86021 Poitiers, France.
  • Snyder JK; INSERM UMR-S 1172, University of Lille 2, 59000 Lille, France.
  • Brown LE; INSERM UMR-S 1172, University of Lille 2, 59000 Lille, France.
  • Gray N; Boston University Center for Molecular Discovery, Boston, MA 02215, USA.
  • Bradner J; Boston University Center for Molecular Discovery, Boston, MA 02215, USA.
  • Whitesell L; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.
  • Porco JA; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.
  • Ghobrial IM; Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.
Sci Transl Med ; 9(389)2017 05 10.
Article em En | MEDLINE | ID: mdl-28490664
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Sci Transl Med Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Sci Transl Med Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2017 Tipo de documento: Article